Suppr超能文献

后路内固定患者脊柱植入物相关手术部位感染的管理与结局:176例分析

Management and outcome of spinal implant-associated surgical site infections in patients with posterior instrumentation: analysis of 176 cases.

作者信息

Hickmann Anne-Katrin, Bratelj Denis, Pirvu Tatiana, Loibl Markus, Mannion Anne F, O'Riordan Dave, Fekete Tamás, Jeszenszky Deszö, Eberhard Nadia, Vogt Marku, Achermann Yvonne, Haschtmann Daniel

机构信息

Department of Spine and Neurosurgery, Schulthess Klinik, Zürich, Switzerland.

Department of Neurosurgery, Kantonsspital St. Gallen, Rorschacher Str. 95, 9000, St. Gallen, Switzerland.

出版信息

Eur Spine J. 2022 Feb;31(2):489-499. doi: 10.1007/s00586-021-06978-y. Epub 2021 Oct 30.

Abstract

PURPOSE

The management of implant-associated surgical site infections (SSI) in patients with posterior instrumentation is challenging. Evidence regarding the most appropriate treatment and the need for removal of implants is equivocal. We sought to evaluate the management and outcome of such patients at our institution.

METHODS

We searched our prospectively documented databases for eligible patients with posterior spinal instrumentation, excluding the cervical spine (January 2008-June 2018). Patient files were reviewed, demographic data and treatment details were recorded. Patient-reported outcome (PRO) was assessed with the Core Outcome Measures Index (COMI) preoperatively and postoperatively at 3 and 12 months.

RESULTS

A total of 170 patients underwent 210 revisions for 176 SSIs. Two-thirds presented within four weeks (105/176, 59.7%, median 22.5d, 7d-11.1y). The most common pathogens were Staphylococcus aureus (n = 79/210, 37.6%) and Staphylococcus epidermidis (n = 56/210, 26.7%). Debridement and implant retention was performed in 135/210 (64.3%) revisions and partial replacement in 62/210 (29.5%). In 28/176 SSI (15.9%), persistent infection required multiple revisions (≤ 4). Surgery was followed by intravenous and oral antimicrobial treatment (10-12w). In 139/176 SSIs (79%) with ≥ 1y follow-up, infection was cured in 115/139 (82.7%); relapse occurred in 9 (relapse rate: 5.1%). Two patients (1.4%) died. COMI decreased significantly (8.2 ± 1.5 vs. 4.8 ± 2.9, p < 0.0001) over 12 months. 72.7% of patients were (very) satisfied with their care.

CONCLUSION

Patients with SSI after posterior (thoraco-)lumbo(-sacral) instrumentation can be successfully treated in most cases with surgical and specific antibiotic treatment. An interdisciplinary approach is recommended. Loose implants should be replaced. In some cases, multiple revisions may be necessary. Patient outcomes were satisfactory.

摘要

目的

后路内固定患者植入物相关手术部位感染(SSI)的管理具有挑战性。关于最合适的治疗方法以及是否需要取出植入物的证据并不明确。我们试图评估我院此类患者的管理及治疗结果。

方法

我们在我院前瞻性记录的数据库中搜索符合条件的后路脊柱内固定患者(不包括颈椎,时间为2008年1月至2018年6月)。查阅患者病历,记录人口统计学数据和治疗细节。采用核心结局指标指数(COMI)在术前以及术后3个月和12个月评估患者报告结局(PRO)。

结果

共有170例患者因176例SSI接受了210次翻修手术。三分之二的患者在4周内出现感染(105/176,59.7%,中位数22.5天,7天至11.1年)。最常见的病原体是金黄色葡萄球菌(n = 79/210,37.6%)和表皮葡萄球菌(n = 56/210,26.7%)。210次翻修手术中有135次(64.3%)进行了清创和保留植入物,62次(29.5%)进行了部分置换。在出现持续性感染的28例SSI患者(15.9%)中,需要进行多次翻修(≤4次)。手术后进行了静脉和口服抗菌治疗(10 - 12周)。在139例随访时间≥1年的SSI患者中(79%),115例(82.7%)感染得到治愈;9例复发(复发率:5.1%)。2例患者(1.4%)死亡。12个月内COMI显著下降(8.2±1.5 vs. 4.8±2.9,p < 0.0001)。72.7%的患者对其治疗(非常)满意。

结论

后路(胸腰段 - 骶段)内固定术后发生SSI的患者,大多数情况下通过手术和特异性抗生素治疗可成功治愈。建议采用多学科方法。松动的植入物应予以更换。在某些情况下,可能需要多次翻修。患者的治疗结果令人满意。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验